Henri Caplain

Comparison of the Pharmacokinetic Profiles of Three Low Molecular Mass Heparins – Dalteparin, Enoxaparin and Nadroparin – Administered Subcutaneously in Healthy Volunteers (Doses for Prevention of Thromboembolism)

F. Collignon, Armand Frydman, Henri Caplain et al. · Thrombosis and Haemostasis · 1995 · 178 citations

Thrombosis, Venous Thrombosis, Pharmacokinetic Modeling +15

Characterizing “Adversity” of Pathology Findings in Nonclinical Toxicity Studies

Xavier Palazzi, John E. Burkhardt, Henri Caplain et al. · Toxicologic Pathology · 2016 · 104 citations

Medical Toxicology, Pathology, Toxicology Testing +16

Pharmacokinetics of nicorandil

Armand Frydman, P Chapelle, H. W. Diekmann et al. · The American Journal of Cardiology · 1989 · 82 citations

Nicotine, Pharmacology, Pharmacotherapy +2

No alteration in platelet function or coagulation induced by EGb761 in a controlled study

Claire Bal dit Sollier, Henri Caplain, Ludovic Drouet · Clinical & Laboratory Haematology · 2003 · 75 citations

Platelet Function, Pathology, Inflammation +17

Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects

Thibaud Damy, Françoise Pousset, Henri Caplain et al. · Fundamental and Clinical Pharmacology · 2004 · 59 citations · Full text